NDC 0068-0597

Rifadin IV

Rifampin

Rifadin IV is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Rifampin.

• Product ID: 0068-0597_00ecaf45-5dc2-4d5b-9436-ed8ebf4b7170
• NDC: 0068-0597
• Product Type: Human Prescription Drug
• Proprietary Name: Rifadin IV
• Generic Name: Rifampin
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 1989-05-25
• Marketing Category: NDA / NDA
• Application Number: NDA050627
• Labeler Name: Sanofi-Aventis U.S. LLC
• Substance Name: RIFAMPIN
• Active Ingredient Strength: 600 mg/10mL
• Pharm Classes: Rifamycin Antibacterial [EPC], Rifamycins [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0068-0597-01

1 VIAL, GLASS in 1 CARTON (0068-0597-01) > 10 mL in 1 VIAL, GLASS

• Marketing Start Date: 1989-05-25
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0068-0597-01 [00068059701]

Rifadin IV INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA050627
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1989-05-25

Drug Details

Active Ingredients

Ingredient	Strength
RIFAMPIN	600 mg/10mL

OpenFDA Data

• SPL SET ID: 036ab68e-5085-4edc-bd83-784b43d64eab
• Manufacturer:
  • Sanofi-Aventis U.S. LLC
• UNII:
  • VJT6J7R4TR
• RxNorm Concept Unique ID - RxCUI:
  • 198202
  • 198201
  • 201868
  • 207436
  • 312821
  • 201867
• UPC Code:
  • 0300680508606

Pharmacological Class

• Rifamycin Antibacterial [EPC]
• Rifamycins [CS]

NDC Crossover Matching brand name "Rifadin IV" or generic name "Rifampin"

NDC	Brand Name	Generic Name
0068-0597	Rifadin IV	rifampin
0068-0508	Rifadin	rifampin
0068-0510	Rifadin	rifampin
0068-0599	Rifadin IV NOVAPLUS	rifampin
0143-9230	Rifampin	Rifampin
0185-0799	Rifampin	Rifampin